Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in FDMT held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLC | 5.7M | $76.5M | — | 10.992% | 0.03% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 5.0M | $67.2M | 0.0% | 9.660% | 0.58% |
| 3 | BlackRock, Inc. | 4.5M | $60.5M | +9.7% | 8.696% | 0.00% |
| 4 | GOLDMAN SACHS GROUP INC | 4.3M | $56.6M | +1.3% | 8.146% | 0.00% |
| 5 | Novo Holdings A/S | 3.2M | $43.2M | -11.0% | 6.215% | 2.51% |
| 6 | STATE STREET CORP | 2.9M | $38.7M | +7.5% | 5.569% | 0.00% |
| 7 | BVF INC/IL | 2.9M | $38.3M | 0.0% | 5.508% | 0.98% |
| 8 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.2M | $29.9M | +40.1% | 4.303% | 0.04% |
| 9 | Trails Edge Capital Partners, LP | 2.2M | $29.6M | +71.0% | 4.262% | 4.70% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | $27.9M | -4.4% | 4.015% | 0.00% |
| 11 | ARMISTICE CAPITAL, LLC | 2.0M | $26.6M | 0.0% | 3.826% | 0.33% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $15.0M | +5.9% | 2.159% | 0.00% |
| 13 | BANK OF AMERICA CORP /DE/ | 1.1M | $14.9M | +15.0% | 2.144% | 0.00% |
| 14 | Evergreen Quality Fund GP, Ltd. | 951K | $12.7M | 0.0% | 1.820% | 0.20% |
| 15 | Parkman Healthcare Partners LLC | 948K | $12.6M | +81.4% | 1.814% | 1.29% |
| 16 | CITADEL ADVISORS LLC | 901K | $12.0M | +184.2% | 1.724% | 0.00% |
| 17 | DIMENSIONAL FUND ADVISORS LP | 731K | $9.7M | +39.8% | 1.398% | 0.00% |
| 18 | DEUTSCHE BANK AG\ | 711K | $9.5M | +0.4% | 1.360% | 0.00% |
| 19 | RENAISSANCE TECHNOLOGIES LLC | 615K | $8.2M | +6.3% | 1.176% | 0.01% |
| 20 | VANGUARD PORTFOLIO MANAGEMENT LLC | 580K | $7.7M | +4.3% | 1.109% | 0.00% |
| 21 | DIADEMA PARTNERS LP | 571K | $7.6M | — | 1.093% | 0.96% |
| 22 | NORTHERN TRUST CORP | 563K | $7.5M | +64.6% | 1.077% | 0.00% |
| 23 | ACUTA CAPITAL PARTNERS, LLC | 508K | $6.8M | — | 0.971% | 4.71% |
| 24 | Nuveen, LLC | 503K | $6.7M | -10.4% | 0.962% | 0.00% |
| 25 | MORGAN STANLEY | 503K | $6.7M | +45.6% | 0.962% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in FDMT — a direct measure of their conviction.
Filings activity in FDMT during Q2 2026, grouped by how each filer changed its position.
Institutions that opened a new FDMT position in Q2 2026
Institutions that fully closed their FDMT position in Q2 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 159 | +5.3% | 112.00% | +9.28 pp | $740M | +57% |
| Q1 2026 | 151 | 0.7% | 102.72% | +4.55 pp | $472M | +18% |
| Q4 2025 | 152 | +17% | 98.17% | +8.73 pp | $400M | +17% |
| Q3 2025 | 130 | +7.4% | 89.44% | 1.94 pp | $343M | +133% |
| Q2 2025 | 121 | 3.2% | 91.38% | 6.04 pp | $147M | +7.8% |
| Q1 2025 | 125 | 14% | 97.42% | 9.44 pp | $136M | 46% |
| Q4 2024 | 146 | +5.0% | 106.86% | 10.44 pp | $255M | 59% |
| Q3 2024 | 139 | — | 117.30% | — | $620M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying FDMT stock.
Based on Q2 2026 13F filings, institutional ownership of 4D Molecular Therapeutics, Inc. stands at 112.0%, held across 159 reporting institutions.
Jupiter Topco LLC is the largest reported institutional holder of FDMT, with approximately 5,746,289 shares worth $0.08B as of Q2 2026.
Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of FDMT, including CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for FDMT is 67 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
28 institutions opened new positions in FDMT during Q2 2026, while 22 fully exited. 104 added to existing positions and 21 trimmed.
FDMT institutional ownership rose by 9.28 percentage points quarter-over-quarter, with a net change of +8 holders.
The top 10 institutions account for 63.3% of all reported 13F value in FDMT, and the top 25 account for 85.4%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
4D Molecular Therapeutics, Inc. (FDMT) Institutional Ownership